The University of California, Office of the President invites comments on a proposed Presidential Policy BFB-BUS-50: Controlled Substances Use In Research and Teaching. The policy is proposed to be revised and includes the following key issues:
- Clarify in detail the scope of duties of the Campus Controlled Substances Programs and the Controlled Substances Program Officers;
- Define the Campus Designation form of Drug Enforcement Agency (DEA) Registration and address requirements applicable to DEA Registrations other than Campus Designation, such as individual schedule I DEA Registrations;
- Provide more specific procedures regarding Powers of Attorney;
- Provide additional guidance as to import, export, interstate and intrastate use, transfer and transport of Controlled Substances, as well as Controlled Substances Analogues and DEA-exempt chemical preparations; and
- Establish responsible units and individuals for patient care and clinical Controlled Substances Program.
The draft policy is posted here. If you have any questions or if you wish to comment, please contact Paula Johnson in Policy and Records Administration at policy@ucsd.edu no later than April 2, 2024.
